Commercialization: Page 90

PharmaVoice Team/PharmaVoice

Opinions

6 J un e 20 03 PharmaVOICE WHAT’S on your mind Breadth and depth I find that industry associations do an excellent job in providing networking, pro fessional continuing education, industry rela tions, and businessdevelopment resources. I can’t speak highly enough about the breadth and depth of op...
By PharmaVoice Team • April 16, 2008
PharmaVoice Team/PharmaVoice

Building a Corporate Identity

8 J u l y 2 00 3 PharmaVOICE E M For the first time, individual companies must establish their own identity with consumers. Executives should focus on identifying their company’s most unique and positive characteristics and communicate them in a single, simple message that can be translated for e...
By Kim Ribbink • April 16, 2008
PharmaVoice Team/PharmaVoice

Wendell J. Knox- Business With Integrity

A contract for strengthening the health system in postconflict Iraq. In its Domestic Social and Economic Poli cy group, Abt Associates works with a wide range of government agencies, including the Environmental Protection Agency, for whom it helps to improve policies and regulations to reduce pol...
By Kim Ribbink • April 16, 2008
PharmaVoice Team/PharmaVoice

You've Got Mail

30 J u l y 20 03 PharmaVOICE D Directmail efforts are one of the industry’s most reliable tools for tar geting and reaching consumers. As email has risen in popularity, the use of postal mail as a directmarketing tool has declined. Industry experts, however, don’t believe that new electronic meth...
By Elisabeth Pena • April 16, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

60 J u l y 20 03 PharmaVOICE Pharma POOL Lynn BAER Dr. Manny BORREGO Novo Nordisk Announces Two Key Appointments for U.S. Medical Department Novo Nordisk, a focused healthcare compa ny and leader in diabetes care, with U.S. headquar ters in Princeton, N.J., has promoted Lynn Baer to senior direct...
By PharmaVoice Team • April 10, 2008
PharmaVoice Team/PharmaVoice

E-Media

56 J u l y 20 03 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Liquent Inc.’s nextgeneration IDRAC regulatory intelligence database is a onesource destination for uptodate regulatory information spanning drug development in 33 countries/regions. IDRAC replac...
By PharmaVoice Team • April 10, 2008
PharmaVoice Team/PharmaVoice

What's New

The first set of international publishing guidelines developed from with in the industry after consultation with journal editors and investigators have been released. The Good Publication Practice (GPP) guidelines call on pharmaceutical companies to publish results of all clinical trials of marke...
By PharmaVoice Team • April 10, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

July 1718,2003,The Watergate Hotel — Washington,D.C. Metabonomics Industry experts will address understanding the metabolic signatures of disease in the postgenomic era; applying metabonomics to toxicity screening and mechanism of action studies; and realizing the potential of metabonomics as an ...
By PharmaVoice Team • April 10, 2008
PharmaVoice Team/PharmaVoice

For Art's Sake

Creative Review OsteoBiFlex, the neckbolted wonder is shown whipping up breakfast and jogging through his suburban neighborhood.There’s something about a jogging Frankenstein with a terrycloth headband that finishes me every time. Real pain,no matter how great or small is seldom funny, but if the...
By PharmaVoice Team • April 10, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

3 PharmaVOICE J u l y 2 00 3 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A....
By Taren Grom • April 10, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Clinical Ink has introduced clinicalink.com, a Website that provides corporate information and detailed explanations of the Clinical Ink eSource solution for the electronic capture and storage of data during clinical trials. The co...
By PharmaVoice Team • March 29, 2008
PharmaVoice Team/PharmaVoice

What's New

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Publicis Selling Solutions Group has created a new divi sion, Publicis Clinical Health Partners, focused on providing integrated behaviorally based education programs for patients and healthcare professionals to optimize patient compliance a...
By PharmaVoice Team • March 29, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

GOLD STANDARD IN ASTHMA TREATMENT is Expected to Emerge A report by Decision Resources projects that for moterol/mometasone, an asthma therapy codevel oped by ScheringPlough and Novartis, will be approved in 2009 and become the clinical gold standard for treating asthma by 2011 because of its com...
By PharmaVoice Team • March 29, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

It’s time to take a fresh look at a big problem — physician access. In a 2008 Arista survey of pharmaceutical managers, almost 90% reported a decrease in face to face physician access over the past five years. What was surprising was the magnitude of the prob lem; pharmaceutical managers ranked p...
By Shelley Spencer • March 29, 2008
PharmaVoice Team/PharmaVoice

Competitive Counter-Strike

In December 1999, ParkeDavis (now Pfizer) launched Lipitor, a very potent LDL cholesterollowering agent. Despite being the fifth statin to enter the U.S. market, Pfizer overwhelmed the competition and soon made Lipitor the topselling cholesterol and pharmaceutical product in the world. By 2002, A...
By PharmaVoice Team • March 29, 2008
PharmaVoice Team/PharmaVoice

Janet Greeson — A Good Samaritan

company had come about from consulting with a doctor who asked her to write about an HIV drug, SP01A, one of the candidates in Samaritan’s pipeline. “I became so interested in the drug, that eventually I found myself pretty much running Steroidogenesis,” she says. The first thing she did upon tak...
By Kim Ribbink • March 29, 2008
PharmaVoice Team/PharmaVoice

25 Years of the Orphan Drug Act

Synthetic drugs accounted for 62% of total orphan drug approvals, and synthetic polypep tides and hormones together accounted for 6%. Among biologics, growth hormones and growth factors together have the largest num ber of approvals at 8% of the total. Market approvals received for plasma product...
By Cynthia Borda • March 27, 2008
PharmaVoice Team/PharmaVoice

Licensed to Sell

A NEW LEGISLATION PROPOSES THAT SALES REPS OBTAIN LICENSES BEFORE THEY CAN MEET WITH PHYSICIANS. The law currently may cause ripples only in Washington,D.C.,but some experts believe its implications will be far reaching. BY ROBIN ROBINSON 0408 Layout PROOFS 3/25/08 11:45 AM Page 58 59 PharmaVOICE...
By PharmaVoice Team • March 27, 2008
PharmaVoice Team/PharmaVoice

Agency Client Services

A SHIFTING LANDSCAPE We asked our agency executives to evaluate what they believe have been the biggest shifts in client service in the past five years. We also asked them to project what they believe the client service role will encompass in the next fiveyears. HOWDOYOUMANAGECLIENTCHALLENGES? DU...
By Taren Grom • March 27, 2008
PharmaVoice Team/PharmaVoice

The Undeniable Power of a Well-Told Tale

23 VIEW on Medical Education Augu s t 20 06 MARKET RESEARCH T here’s nothing as good as a good story. Since the beginning of history (oral, that is), storytelling has been one of the most powerful forms of communication. A good story conveys facts: What happened? To whom? When? But a good story i...
By PharmaVoice Team • March 25, 2008
PharmaVoice Team/PharmaVoice

Supplier Showcase

Showcase 34 Ma r ch 20 08 VIEW on Advertising AbelsonTaylor, Inc. 33 W. Monroe St. Suite 600 Chicago, IL 60603 Phone: 3128945500 www.abelsontaylor.com Extra Strength Branding The largest independently owned medical agency in the world? AbelsonTaylor. An agency that specialized in pharma, biotech,...
By PharmaVoice Team • March 25, 2008
PharmaVoice Team/PharmaVoice

The Elusive, Impossible Quest for True ROI

32 Ma r ch 20 08 VIEW on Advertising ROI E verybody eagerly wants ROI. And, everybody eagerly wants to deliver it. Many people will even go so far as to boldly “guaran tee” it. Everybody throws the concept of return on investment (ROI) around with an air of confidence that we really know what it ...
By PharmaVoice Team • March 25, 2008
PharmaVoice Team/PharmaVoice

Reframing Negative Industry Perceptions With Patient Education

30 Ma r ch 20 08 VIEW on Advertising PATIENT EDUCATION E ven without a crystal ball, it seems likely that public scrutiny of directtoconsumer advertis ing (DTC) will continue. Although DTC spending accounts for only 7% to 14% of pharmaceutical market ing budgets,* DTC’s broad reach has made pharm...
By PharmaVoice Team • March 25, 2008
PharmaVoice Team/PharmaVoice

Connecting Your Brand in an On-Demand World

28 Ma r ch 20 08 VIEW on Advertising ONDEMAND COMMUNICATIONS L et’s face it, everything in the medical com munications world is in flux. Digital commu nications are more immediate, more pervasive, and more viral. Patients and legislators are demanding immediate release of clinical trial results, ...
By PharmaVoice Team • March 25, 2008
PharmaVoice Team/PharmaVoice

Messaging Payers: The Key to Unlocking Market Access

26 Ma r ch 20 08 VIEW on Advertising MARKET RESEARCH I n today’s reimbursement environment, private and govern ment payers are more influential than ever, managing more than 85% of US prescription drug expenditures. Part D of the Medicare Pre scription Drug Improvement and Modernization Act (MMA)...
By PharmaVoice Team • March 25, 2008